Emphysema affects the air sacs (alveoli) in your lungs, and chronic bronchitis
affects your airways (bronchi). If you have COPD, you might have just one of
these conditions, or you might have more than one. Most COPD patients have
varying degrees of both emphysema and chronic bronchitis.
With COPD, your airways become inflamed and the air sacs in your lungs are
damaged. This causes your airways to become narrower, which makes it harder
to breathe in and out. These breathing difficulties can affect many aspects of
your daily life.
These statistics on COPD in the UK were compiled as part of our Respiratory Health of the
Nation project by teams at St George’s, University of London, Nottingham University and
Imperial College London.
Our research also suggests that prevalence is growing. The number of people who have
ever had a diagnosis of COPD has increased by 27% in the last decade, from under 1,600
to nearly 2,000 per 100,000. This could mean that more undiagnosed cases are being
found, or that the disease is becoming more common. Changes in record-keeping could
also be a factor.
2004 991,263
2005 1,018,732
2006 1,047,681
2007 1,094,567
2008 1,126,562
2009 1,161,975
2010 1,176,456
2011 1,222,113
2012 1,201,685
How many people have been diagnosed with COPD in
each region of the UK?
There was a higher proportion of people diagnosed with COPD in the north of the UK –
Scotland and the North East and North West of England. This was seen throughout the
years 2004–12.
2004 1,713 1,354 1,457 2,240 2,210 1,895 2,202 1,220 1,406 2,088 1,661 1,888
2005 1,740 1,404 1,522 2,297 2,318 2,091 2,107 1,336 1,412 1,999 1,719 1,806
2006 1,799 1,451 1,614 2,345 2,326 2,009 2,147 1,354 1,486 2,058 1,694 1,858
2007 1,811 1,576 1,670 2,427 2,366 2,116 2,325 1,397 1,542 2,085 1,754 1,882
2008 1,818 1,576 1,767 2,511 2,399 2,063 2,217 1,447 1,593 2,106 1,784 1,893
2009 1,853 1,629 1,778 2,581 2,409 2,090 2,252 1,468 1,612 2,078 1,817 1,985
2010 1,872 1,630 1,821 2,477 2,372 2,083 2,274 1,509 1,639 2,078 1,806 1,868
2011 1,900 1,749 1,869 2,530 2,427 2,079 2,319 1,549 1,690 2,139 1,895 1,840
2012 2,055 1,763 1,909 2,600 2,452 2,115 2,369 1,612 1,748 2,173 1,916 2,008
2004 226
2005 219
2006 207
2007 204
2008 193
2009 186
2010 187
2011 197
2012 193
2004 230 203 202 333 286 335 274 186 226 249 222 255
2005 198 185 234 285 295 316 233 204 212 245 209 180
2006 237 171 215 292 262 248 237 183 202 225 196 173
2007 199 194 211 328 245 204 250 173 193 218 207 174
2008 177 185 202 269 237 191 222 172 190 193 195 158
2009 186 191 202 277 227 181 221 149 165 194 182 206
2010 201 201 187 221 235 185 232 154 160 184 169 223
2011 192 194 193 248 246 159 241 160 176 219 192 174
2012 209 163 196 177 234 187 238 170 172 197 175 197
Number of males and females ever diagnosed with COPD per 100,000,
2004–12
MaleFemale2004200620082010201205001,0001,5002,0002,500
Year Male Female
Number of males and females per 100,000 newly diagnosed with COPD
each year, 2004–12
MaleFemale20042006200820102012050100150200250300
Year Male Female
Number of people ever diagnosed with COPD per 100,000, by age group,
2004–12
31 to 4041 to 5051 to 6061 to 7071 to 8081 and
over2004200620082010201201,0002,0003,0004,0005,0006,0007,0008,0009,000
31 41 81
51 to 61 to 71 to
Year to to and
60 70 80
40 50 over
Kyrgyzstan 696.3
Colombia 344.6
Philippines 316.1
Republic of
307.6
Moldova
Denmark 289.9
Brazil 273.8
United States
248.2
of America
Mexico 242.8
Hungary 220.4
United
210.7
Kingdom
Maldives 201.3
Age-
standardised
Country mortality rate
(per million of
population)
Netherlands 194.6
Uruguay 192.3
Ireland 191.7
Belgium 190.6
Venezuela 185.2
Norway 178.5
Bahrain 175.9
Panama 170.3
Cuba 165.1
Romania 164.9
Canada 164.3
Nicaragua 162.2
Hong Kong
160
SAR
Iceland 159.7
Chile 153.3
Lithuania 150.3
Belize 148.7
Uzbekistan 144.2
Australia 143.2
Austria 141.9
Spain 139.9
Luxembourg 138.1
Jamaica 131.8
Croatia 131.4
Serbia 131.2
Malta 128.7
Germany 125.5
Slovenia 122
Italy 115.9
Poland 114.3
Sweden 113.6
TFYR
112
Macedonia
Egypt 110.7
Israel 107.1
Czech
106.7
Republic
Portugal 104.4
Republic of
104.3
Korea
Bulgaria 100.8
Guatemala 97.8
Finland 96.2
Slovakia 93.3
Argentina 92.9
Jordan 90.4
Ecuador 90.2
Age-
standardised
Country mortality rate
(per million of
population)
Trinidad and
90.1
Tobago
Reunion 89
Grenada 87.1
Malaysia 85
Suriname 76.7
El Salvador 75.7
Guyana 75.4
Estonia 71.2
Thailand 66.7
Mauritius 66.1
Saint Vincent
and 65.8
Grenadines
Fiji 61.2
Latvia 59.5
Peru 57.9
Qatar 56.6
Cyprus 55.5
Paraguay 54.8
Dominican
53.8
Republic
France 52
French
50.6
Guiana
Virgin
Islands 49.4
(USA)
Age-
standardised
Country mortality rate
(per million of
population)
Occupied
Palestinian 47.4
Territory
Bahamas 43.3
Japan 40.9
Aruba 34.5
Barbados 32.2
Kuwait 28.9
Oman 21.4
Georgia 18.6
Azerbaijan 16.6
Guadeloupe 16
Martinique 15
Bolivia 12.7
Iraq 7.6
Morocco 4.3
Montenegro 2.6
Haiti 1.8
Along with lung cancer and pneumonia, COPD is one of the three leading contributors to
respiratory mortality in developed countries such as the UK.
COPD 29,776
Pneumonia 28,952
Idiopathic
pulmonary 5,292
fibrosis
Lung diseases
due to external 4,171
agents
Pleural
2,431
mesothelioma
Pulmonary
2,275
embolism
Acute lower
respiratory 1,589
infections
Bronchiectasis 1,567
Asthma 1,246
Other pulmonary
594
vascular diseases
Respiratory TB 282
Sarcoidosis 170
Acute respiratory
127
failure
Disease Deaths
Perinatal and
congenital
119
respiratory
conditions
Influenza 104
Scotland: COPD mortality rates were higher than in the UK generally, but similar to
northern England. The relative differences were greater among females than males.
Wales: The death rate from COPD was slightly higher than in the UK generally.
Northern Ireland: Death rates for COPD were similar to rates for the UK generally, with a
slight increase among males.
Yorkshire &
101 109
Humberside
East Midlands 95 90
East of
83 77
England
London 95 86
South West 86 74
Northern
105 101
Ireland
United
100 100
Kingdom
© Copyright info
Relative risk is used in medical research to compare risk in different groups of people. In
the maps we show the risk of an area (local authority district) relative to the average for
Scotland, England and Wales. Here we show whether the group of people living in a
particular area have a risk of dying from COPD that is lower or higher than the average.
Because of the way relative risk is calculated there must always be some areas above
average and some below average.
In London, admission rates for males were higher, while female admission rates were
similar to the UK generally.
Admission rates were notably lower in the East of England, South East and South West
than in the UK generally.
Scotland: Rates of admission were higher compared with the UK generally, with more
females admitted than males.
Wales: Rates of admission were higher compared with the UK generally, with no significant
difference between males and females.
Northern Ireland: Rates of admission were higher compared with the UK generally, with
more males admitted than females.
Yorkshire &
114 122
Humberside
East Midlands 93 84
West Midlands 97 88
East of
76 68
England
London 109 90
South East 74 67
South West 72 62
Northern
139 129
Ireland
United
100 100
Kingdom
© Copyright info
Relative risk is used in medical research to compare risk in different groups of people. In
the maps we show the risk of an area (local authority district) relative to the average for
Scotland, England and Wales. Here we show whether the group of people living in a
particular area have a risk of emergency admission to hospital from COPD that is lower or
higher than the average. Because of the way relative risk is calculated there must always be
some areas above average and some below average.
Methodology
How were these figures calculated?
Find out how the numbers of people with COPD, deaths and hospital admissions were
calculated: Methodology - numbers, deaths and admissions
https://statistics.blf.org.uk/copd